Historical coo News Stories
CooperCompanies: Board Shakeup Spurs COO Rally Now
CooperCompanies (COO) saw a governance change and launched a formal strategic review the past week, accompanied by strong Q4 results, an expanded buyback program and bullish 2026 guidance—moves that pushed shares higher and prompted analyst target upgrades. This article breaks down the concrete developments, financials, and investor implications for the vision-care and women’s-health business units.
COO Upside: March 5 Earnings & Board Shakeup Ahead
CooperCompanies (COO) faces a pivotal week as it reports Q1 on March 5. Board leadership changes, a formal strategic review and activist cooperation have set clear near-term catalysts.
CooperCompanies COO: Board Shakeup Fuels Value Up
CooperCompanies (COO) has moved decisively on governance and capital allocation: a board refresh linked to activist Browning West, fiscal 2025 results showing modest organic growth, a $1B bump to buyback capacity, and a strategic review that could reshape CooperVision and CooperSurgical. These concrete actions — plus FY2026 guidance and cost-savings targets — create a clearer near-term playbook for investors.